Goldman, A P <br/><br/>
Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations.  [electronic resource] 

 -  The Annals of thoracic surgery  Aug 1995 
 - 300-5; discussion 306 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4975 
<br/><br/><label>Standard No.: </label>10.1016/0003-4975(95)00408-d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cross-Over Studies<br/>Epoprostenol--therapeutic use<br/>Female<br/>Heart Defects, Congenital--complications<br/>Hemodynamics<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Nitric Oxide--therapeutic use<br/>Postoperative Complications<br/>Prospective Studies<br/>Treatment Outcome